-
COVID-19 vaccine stirs rare hesitation in nearly virus-free Singapore
expresspharma
December 23, 2020
The first shipment of the Pfizer-BioNTech vaccine arrived this week and Singapore expects to have enough vaccines for all 5.7 million people by the third quarter of 2021.
-
EC orders additional 80 million doses of Moderna’s COVID-19 vaccine
europeanpharmaceuticalreview
December 22, 2020
Europe will receive an extra 80 million doses of Moderna’s mRNA-1273, a COVID-19 vaccine candidate, following the EC’s decision.
-
US CDC committee recommends Moderna’s Covid-19 vaccine for use in adults
pharmaceutical-technology
December 22, 2020
The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend the use of Moderna’s Covid-19 vaccine in adults under the Emergency Use Authorisation (EUA) issued by the US Food and Drug ...
-
FDA investigates allergic reactions of Pfizer Covid-19 vaccine in US
pharmaceutical-technology
December 22, 2020
The US Food and Drug Administration (FDA) has started investigating around five allergic reactions that occurred after individuals received Pfizer and BioNTech’s Covid-19 shot.
-
FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
worldpharmanews
December 21, 2020
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
-
Scancell picks lead COVID-19 vaccine candidate
pharmatimes
December 21, 2020
UK-based Scancell Holdings has selected a lead COVID-19 vaccine candidate – SN14 – to advance through further development and into clinical trials.
-
European Commission to purchase additional 80 mn doses of Moderna’s COVID-19 vaccine
expresspharma
December 21, 2020
Moderna announced that the European Commission has exercised its option to purchase an additional 80 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 160 million doses.
-
COVAX Alliance secures two billion doses of COVID-19 vaccines
expresspharma
December 21, 2020
It aims to deliver 1.3 billion doses of approved vaccines next year to 92 eligible low- and middle-income economies.
-
Shadowfax to collaborate with SpiceXpress for COVID-19 vaccines transportation
expresspharma
December 21, 2020
Shadowfax will engage 250+ cold storage fleets with cold chain readiness to move the vaccine across 7000+ pin codes in India.
-
BioNTech and Fosun to supply 100 million Covid-19 vaccine doses to China
pharmaceutical-technology
December 18, 2020
German company BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have entered into an agreement to supply initially 100 million doses of mRNA-based Covid-19 vaccine candidate, BNT162, to Mainland China next year.